Why the study?
The study was conducted to evaluate the predictors and safety of next-day discharge after transfemoral TAVI in unselected patients receiving either balloon-expandable or self-expanding devices.
Does next-day discharge maintain safety and clinical outcomes compared to later discharge in patients undergoing transfemoral transcatheter aortic valve implantation?
Does next-day discharge maintain safety and clinical outcomes compared to later discharge in patients undergoing transfemoral transcatheter aortic valve implantation?
Next-day discharge after uncomplicated transfemoral TAVI is safe up to one year, with prior permanent pacemaker and preprocedural CTA being significant predictors of successful early discharge.
No takes yet. Share an insight, caveat, or question.
May support next-day discharge after uncomplicated TAVI; leaves open need for randomized confirmation before practice change.
Costa et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: